This Article Full Text Full Text (PDF) All Versions of this Article: 21/1/215    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cleasby, M. E. Articles by Kraegen, E. W. Search for Related Content PubMed PubMed Citation Articles by Cleasby, M. E. Articles by Kraegen, E. W.

Functional Studies of Akt Isoform Specificity in Skeletal Muscle in Vivo; Maintained Insulin Sensitivity Despite Reduced Insulin Receptor Substrate-1 Expression

Diabetes and Obesity Program (M.E.C., T.A.R., G.J.C., D.E.J., E.W.K.), Garvan Institute of Medical Research; St. Vincent’s Clinical School (G.J.C., E.W.K.), Faculty of Medicine, University of New South Wales; and School of Biotechnology and Biomolecular Sciences (D.E.J.), Faculty of Science, University of New South Wales, Sydney, Australia

Address all correspondence and requests for reprints to: Dr. Mark E. Cleasby, Diabetes and Obesity Program, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, New South Wales 2010, Australia. E-mail: M.Cleasby{at}garvan.org.au.

The phosphoinositide 3-kinase/Akt pathway is thought to be essential for normal insulin action and glucose metabolism in skeletal muscle and has been shown to be dysregulated in insulin resistance. However, the specific roles of and signaling pathways triggered by Akt isoforms have not been fully assessed in muscle in vivo. We overexpressed constitutively active (ca-) Akt-1 or Akt-2 constructs in muscle using in vivo electrotransfer and, after 1 wk, assessed the roles of each isoform on glucose metabolism and fiber growth. We achieved greater than 2.5-fold increases in total Ser473 phosphorylation in muscles expressing ca-Akt-1 and ca-Akt-2, respectively. Both isoforms caused hypertrophy of muscle fibers, consistent with increases in p70S6kinase phosphorylation, and a 60% increase in glycogen accumulation, although only Akt-1 increased glycogen synthase kinase-3ß phosphorylation. Akt-2, but not Akt-1, increased basal glucose uptake (by 33%, P = 0.004) and incorporation into glycogen and lipids, suggesting a specific effect on glucose transport. Consistent with this, short hairpin RNA-mediated silencing of Akt-2 caused reductions in glycogen storage and glucose uptake. Consistent with Akt-mediated insulin receptor substrate 1 (IRS-1) degradation, we observed approximately 30% reductions in IRS-1 protein in muscle overexpressing ca-Akt-1 or ca-Akt-2. Despite this, we observed no decrease in insulin-stimulated glucose uptake. Furthermore, a 68% reduction in IRS-1 levels induced using short hairpin RNAs targeting IRS-1 also did not affect glucose disposal after a glucose load. These data indicate distinct roles for Akt-1 and Akt-2 in muscle glucose metabolism and that moderate reductions in IRS-1 expression do not result in the development of insulin resistance in skeletal muscle in vivo.

This article has been cited by other articles:

				O. Schakman, S. Kalista, L. Bertrand, P. Lause, J. Verniers, J. M. Ketelslegers, and J. P. Thissen Role of Akt/GSK-3{beta}/{beta}-Catenin Transduction Pathway in the Muscle Anti-Atrophy Action of Insulin-Like Growth Factor-I in Glucocorticoid-Treated Rats Endocrinology, August 1, 2008; 149(8): 3900 - 3908. [Abstract] [Full Text] [PDF]

				E. Polkinghorne, Q. Lau, G. J. Cooney, E. W. Kraegen, and M. E. Cleasby Local activation of the I{kappa}K-NF-{kappa}B pathway in muscle does not cause insulin resistance Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E316 - E325. [Abstract] [Full Text] [PDF]

				A. J. Hoy, C. R. Bruce, A. Cederberg, N. Turner, D. E. James, G. J. Cooney, and E. W. Kraegen Glucose infusion causes insulin resistance in skeletal muscle of rats without changes in Akt and AS160 phosphorylation Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1358 - E1364. [Abstract] [Full Text] [PDF]